Anti-Inflammatory Drugs Market Size, Share & Industry Analysis, By Drug Class (Anti-inflammatory Biologics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids), By Application (Autoimmune Inflammatory Diseases (Rheumatoid Arthritis Psoriasis), Respiratory Diseases), By Route of Administration (Oral, Injection, Inhalation, and Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), and Regional Forecast, 2020-2032

 ATTRIBUTE

 DETAILS

Study Period

  2016-2027

Base Year

  2019

Forecast Period

  2020-2027

Historical Period

  2016-2018

Unit

  Value (USD billion)

Segmentation

By Drug Class

• Anti-inflammatory Biologics


• Non-steroidal Anti-inflammatory Drugs (NSAIDs)


• Corticosteroids

By Application

• Autoimmune Inflammatory Diseases
  
  
  
  • Rheumatoid Arthritis
  
  
  • Psoriasis
  
  
  • Others
  
  
  
  


• Respiratory Diseases


• Others 

By Route of Administration

• Oral


• Injection


• Topical


• Inhalation

By Distribution Channel

• Hospital Pharmacy


• Retail Pharmacy


• Online Pharmacy

By Geography

• North America (the U.S. and Canada)


• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)


• Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)


• Latin America (Brazil, Mexico, and the Rest of Latin America)


• Middle East& Africa (South Africa, GCC and the Rest of Middle East & Africa)